Management of Gastric Varices

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 6, 2014, Pages

  Garcia Pagán, Juan Carlos ^a   Barrufet, Marta ^b   Cardenas, Andres ^c   Escorsell, Àngels ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Balloon occluded retrograde transvenous obliteration (BRTO); Cirrhosis; Cyanoacrylate; Gastric varices; Portal hypertension; Transjugular intrahepatic portosystemic shunt (Tips); Variceal bleeding

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; PROPRANOLOL; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; TERLIPRESSIN; THROMBIN; TISSUE ADHESIVE; VASOACTIVE AGENT; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CYANOACRYLATE DERIVATIVE;

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; HEMOSTASIS; HUMAN; IATROGENIC DISEASE; LIVER DYSFUNCTION; MEDICAL PROCEDURES; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; STOMACH VARICES; STOMACH VARICES BLEEDING; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE; BALLOON OCCLUSION; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; PROCEDURES;

ANTI-BACTERIAL AGENTS; BALLOON OCCLUSION; CARDIOVASCULAR AGENTS; CYANOACRYLATES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROPRANOLOL; TISSUE ADHESIVES;

EID: 84901229601     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.07.015     Document Type: Article

References (77)

1. Sarin S.K., Lahoti D., Saxena S.P., et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992, 16:1343-1349.
2. Kim T., Shijo H., Kokawa H., et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997, 25:307-312.
3. Mishra S.R., Sharma B.C., Kumar A., et al. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol 2011, 54:1161-1167.
4. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010, 53:762-768.
5. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007, 46:922-938.
6. Escorsell A., Abraldes J.G., Pipa-Muñiz M., et al. Prognosis of acute bleeding from isolated fundal varices in patients with cirrhosis: a European cohort. Hepatology 2012, 56(Suppl):748A.
7. Tan P.C., Hou M.C., Lin H.C., et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 2006, 43:690-697.
8. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001, 33:1060-1064.
9. Oho K., Iwao T., Sumino M., et al. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995, 27:349-354.
10. Sarin S.K., Jain A.K., Jain M., et al. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002, 97:1010-1015.
11. Lo G.H., Lai K.H. Should GOV1 be treated as for esophageal varices?. Gastroenterology 2004, 127:1014-1015.
12. Greenwald B.D., Caldwell S.H., Hespenheide E.E., et al. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol 2003, 98:1982-1988.
13. Caldwell S.H., Hespenheide E.E., Greenwald B.D., et al. Enbucrilate for gastric varices: extended experience in 92 patients. Aliment Pharmacol Ther 2007, 26:49-59.
14. Seewald S., Ang T.L., Imazu H., et al. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc 2008, 68:447-454.
15. Wang Y.M., Cheng L.F., Li N., et al. Study of glue extrusion after endoscopic N-butyl-2-cyanoacrylate injection on gastric variceal bleeding. World J Gastroenterol 2009, 15:4945-4951.
16. Cheng L.F., Wang Z.Q., Li C.Z., et al. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol 2010, 8:760-766.
17. Joo H.S., Jang J.Y., Eun S.H., et al. [Long-term results of endoscopic histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices: a 10-year experience]. Korean J Gastroenterol 2007, 49:320-326.
18. Teres J., Cecilia A., Bordas J.M., et al. Esophageal tamponade forbleeding varices: controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 1978, 75:566-569.
19. Chau T.N., Patch D., Chan Y.W., et al. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998, 114:981-987.
20. Azoulay D., Castaing D., Majno P., et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001, 35:590-597.
21. Gaba R.C., Bui J.T., Cotler S.J., et al. Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization. Hepatol Int 2010, 4:749-756.
22. Xiao T., Chen L., Chen W., et al. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. J Clin Gastroenterol 2011, 45:643-650.
23. Mahadeva S., Bellamy M.C., Kessel D., et al. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 2003, 98:2688-2693.
24. Garcia-Pagan J.C., Caca K., Bureau C., et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010, 362:2370-2379.
25. Rajoriya N., Forrest E.H., Gray J., et al. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM 2011, 104:41-47.
26. Choudhuri G., Chetri K., Bhat G., et al. Long-term efficacy and safety of N-butylcyanoacrylate in endoscopic treatment of gastric varices. Trop Gastroenterol 2010, 31:155-164.
27. Belletrutti P.J., Romagnuolo J., Hilsden R.J., et al. Endoscopic management of gastric varices: efficacy and outcomes of gluing with N-butyl-2-cyanoacrylate in a North American patient population. Can J Gastroenterol 2008, 22:931-936.
28. Marques P., Maluf-Filho F., Kumar A., et al. Long-term outcomes of acute gastric variceal bleeding in 48 patients following treatment with cyanoacrylate. Dig Dis Sci 2008, 53:544-550.
29. Fry L.C., Neumann H., Olano C., et al. Efficacy, complications and clinical outcomes of endoscopic sclerotherapy with N-butyl-2-cyanoacrylate for bleeding gastric varices. Dig Dis 2008, 26:300-303.
30. Cheng L.F., Wang Z.Q., Li C.Z., et al. Treatment of gastric varices by endoscopic sclerotherapy using butyl cyanoacrylate: 10 years' experience of 635 cases. Chin Med J (Engl) 2007, 120:2081-2085.
31. Evrard S., Dumonceau J.M., Delhaye M., et al. Endoscopic histoacryl obliteration vs propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy 2003, 35:729-735.
32. Mishra S.R., Chander S.B., Kumar A., et al. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut 2010, 59:729-735.
33. Binmoeller K.F., Weilert F., Shah J.N., et al. EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection (with videos). Gastrointest Endosc 2011, 74:1019-1025.
34. Hung H.H., Chang C.J., Hou M.C., et al. Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol 2012, 56:1025-1032.
35. McAvoy N.C., Plevris J.N., Hayes P.C. Human thrombin for the treatment of gastric and ectopic varices. World J Gastroenterol 2012, 18:5912-5917.
36. Krystallis C., McAvoy N.C., Wilson J., et al. EUS-assisted thrombin injection for ectopic bleeding varices: a case report and review of the literature. QJM 2012, 105:355-358.
37. Ramesh J., Limdi J.K., Sharma V., et al. The use of thrombin injections in the management of bleeding gastric varices: a single-center experience. Gastrointest Endosc 2008, 68:877-882.
38. Heneghan M.A., Byrne A., Harrison P.M. An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices. Gastrointest Endosc 2002, 56:422-426.
39. Yang W.L., Tripathi D., Therapondos G., et al. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol 2002, 97:1381-1385.
40. Przemioslo R.T., McNair A., Williams R. Thrombin is effective in arresting bleeding from gastric variceal hemorrhage. Dig Dis Sci 1999, 44:778-781.
41. Williams S.G., Peters R.A., Westaby D. Thrombin: an effective treatment for gastric variceal haemorrhage. Gut 1994, 35:1287-1289.
42. Yang Z., Han G., Wu Q., et al. Patency and clinical outcomes oftransjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010, 25:1718-1725.
43. Lo G.H., Liang H.L., Chen W.C., et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007, 39:679-685.
44. Procaccini N.J., Al-Osaimi A.M., Northup P., et al. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center US analysis. Gastrointest Endosc 2009, 70:881-887.
45. Kanagawa H., Mima S., Kouyama H., et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996, 11:51-58.
46. Hirota S., Matsumoto S., Tomita M., et al. Retrograde transvenous obliteration of gastric varices. Radiology 1999, 211:349-356.
47. Kiyosue H., Mori H., Matsumoto S., et al. Transcatheter obliteration of gastric varices: part 2-strategy and techniques based on hemodynamic features. Radiographics 2003, 23:921-937.
48. Kiyosue H., Mori H., Matsumoto S., et al. Transcatheter obliteration of gastric varices: part 1-anatomic classification. Radiographics 2003, 23:911-920.
49. Al-Osaimi A.M., Sabri S.S., Caldwell S.H. Balloon-occluded retrograde transvenous obliteration (BRTO): preprocedural evaluation and imaging. Semin Intervent Radiol 2011, 28:288-295.
50. Cho S.K., Shin S.W., Lee I.H., et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol 2007, 189:W365-W372.
51. Sonomura T., Sato M., Kishi K., et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol 1998, 21:27-30.
52. Fukuda T., Hirota S., Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001, 12:327-336.
53. Kitamoto M., Imamura M., Kamada K., et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol 2002, 178:1167-1174.
54. Choi Y.H., Yoon C.J., Park J.H., et al. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol 2003, 4:109-116.
55. Ninoi T., Nishida N., Kaminou T., et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol 2005, 184:1340-1346.
56. Hiraga N., Aikata H., Takaki S., et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol 2007, 42:663-672.
57. Akahoshi T., Hashizume M., Tomikawa M., et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol 2008, 23:1702-1709.
58. Kumamoto M., Toyonaga A., Inoue H., et al. Long-term results ofballoon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol 2010, 25:1129-1135.
59. Sabri S.S., Swee W., Turba U.C., et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011, 22:309-316.
60. Akahoshi T., Tomikawa M., Kamori M., et al. Impact of balloon-occluded retrograde transvenous obliteration on management of isolated fundal gastric variceal bleeding. Hepatol Res 2012, 42:385-393.
61. Choi S.Y., Won J.Y., Kim K.A., et al. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur Radiol 2011, 21:122-129.
62. Clements W., Cavanagh K., Ali F., et al. Variant treatment for gastric varices with polidocanol foam using balloon-occluded retrograde transvenous obliteration: a pilot study. J Med Imaging Radiat Oncol 2012, 56:599-605.
63. Saad W.E. The history and evolution of balloon-occluded retrograde transvenous obliteration (BRTO): from the United States to Japan and back. Semin Intervent Radiol 2011, 28:283-287.
64. Patel A., Fischman A.M., Saad W.E. Balloon-occluded retrograde transvenous obliteration of gastric varices. AJR Am J Roentgenol 2012, 199:721-729.
65. Hong C.H., Kim H.J., Park J.H., et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 2009, 24:372-378.
66. Saad W.E., Sabri S.S. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin Intervent Radiol 2011, 28:333-338.
67. Ninoi T., Nakamura K., Kaminou T., et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR Am J Roentgenol 2004, 183:369-376.
68. Saad W.E., Al-Osaimi A.M., Caldwell S.H. Pre- and post-balloon-occluded retrograde transvenous obliteration clinical evaluation, management, and imaging: indications, management protocols, and follow-up. Tech Vasc Interv Radiol 2012, 15:165-202.
69. Ogawa K., Ishikawa S., Naritaka Y., et al. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding. J Gastroenterol Hepatol 1999, 14:245-250.
70. Kind R., Guglielmi A., Rodella L., et al. Bucrylate treatment of bleeding gastric varices: 12 years' experience. Endoscopy 2000, 32:512-519.
71. Huang Y.H., Yeh H.Z., Chen G.H., et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2- cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000, 52:160-167.
72. Akahoshi T., Hashizume M., Shimabukuro R., et al. Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery 2002, 131(Suppl):S176-S181.
73. Rengstorff D.S., Binmoeller K.F. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans. Gastrointest Endosc 2004, 59:553-558.
74. Mumtaz K., Majid S., Shah H., et al. Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleeding. World J Gastroenterol 2007, 13:1247-1251.
75. Paik C.N., Kim S.W., Lee I.S., et al. The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome. J Clin Gastroenterol 2008, 42:916-922.
76. Monsanto P., Almeida N., Rosa A., et al. Endoscopic treatment of bleeding gastric varices with histoacryl (N-butyl-2-cyanoacrylate): a South European single center experience. Indian J Gastroenterol 2012, 32:227-231.
77. Hou M.C., Lin H.C., Lee H.S., et al. A randomized trial of endoscopic cyanoacrylate injection for acute gastric variceal bleeding: 0.5 mL versus 1.0 mL. Gastrointest Endosc 2009, 70:668-675.